Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secular trends in stroke incidence and mortality

J Grotta

    Stroke
    |April 1, 1993
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Treatment of adult moyamoya disease by encephalo-duro-arterio-synangiosis: Five case reports.

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
    Same author

    Does the cognitive measure Cog-4 show improvement among patients treated with thrombolysis after acute stroke?

    International journal of stroke : official journal of the International Stroke Society·2012
    Same author

    Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.

    Cerebrovascular diseases (Basel, Switzerland)·2001
    Same author

    Combination therapy stroke trial. rt-PA +/- lubeluzole.

    Annals of the New York Academy of Sciences·2001
    Same author

    Lubeluzole in acute ischemic stroke treatment: A double-blind study with an 8-hour inclusion window comparing a 10-mg daily dose of lubeluzole with placebo.

    Stroke·2000
    Same author

    Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial.

    Stroke·2000